Skip to main content
Clinical Trials/NCT01742923
NCT01742923
Completed
Not Applicable

Pharmacist Intervention Programme in Secondary Care to Improve Medication Adherence in Patients With Hypertension

Odense University Hospital1 site in 1 country532 target enrollmentDecember 2012
ConditionsHypertension

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
Odense University Hospital
Enrollment
532
Locations
1
Primary Endpoint
Percent of patients that are at least 80% adherent (Medication possession rate > 0.8) to antihypertensives and statins
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

Patients with hypertension have an increased risk of stroke and myocardial infarction. However, poor adherence to treatment with antihypertensives and lipid-lowering agents occurs frequently within this patient group. The purpose of this study is to investigate whether a complex tailored intervention in a hospital setting will lead to increased medication adherence and fewer cardiovascular events when compared to a usual care group. Interventions focus on motivational interviewing, medication review and telephone follow up.

Registry
clinicaltrials.gov
Start Date
December 2012
End Date
September 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ulla Hedegaard

PhD student, MSc (pharm), Odense University Hospital

Odense University Hospital

Eligibility Criteria

Inclusion Criteria

  • Age: 18 years or older
  • Patients receiving ambulatory treatment for hypertension in a hospital setting
  • The patient or a carer usually dispenses the patient's medications
  • Patient lives in the Southern Region of Denmark
  • Written consent

Exclusion Criteria

  • Lives in a care home or institution
  • Receive dose dispensed medicine from a pharmacy
  • Medicine is dispensed by a nurse in the patient's home
  • Correctional mental health patients

Outcomes

Primary Outcomes

Percent of patients that are at least 80% adherent (Medication possession rate > 0.8) to antihypertensives and statins

Time Frame: One year from inclusion

Secondary Outcomes

  • Non-persistence with antihypertensives and statins measured by percent of patients that are not supplied with medications for more than three continuous months(One year from inclusion)
  • Reduction in systolic and diastolic blood pressure(One year from inclusion)
  • Composite endpoint (stroke, myocardial infarction or cardiovascular death)(One year from inclusion)

Study Sites (1)

Loading locations...

Similar Trials